Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa.
Malignant melanomas of the oral and sinonasal mucosa are rare tumors. Amelanotic variants can, on occasion, be difficult to recognize by routine light microscopy. Immunohistochemical studies may be needed for a final diagnosis. A number of new monoclonal antibodies to melanocytic differentiation antigens have been studied recently on primary cutaneous and metastatic melanoma. However, little is known about these antibodies for the diagnosis of mucosal melanomas. In this study the authors analyzed 79 oral and sinonasal mucosal melanomas of 65 patients. A total of 35 tumors originated from the oral mucosa (21 primary tumors, eight local recurrences, and six metastases) and 44 melanomas were from the sinonasal tract (27 primary tumors, nine local recurrences, and eight metastases). Immunohistochemical studies were performed on paraffin-embedded tissues, using the following antibodies: anti-S-100 protein, T311 (anti-tyrosinase), A103 (anti-Mart-1/Melan-A), D5 (antimicrophthalmia-associated transcription factor), and HMB-45 (anti-gp100). Of 35 oral mucosal tumors, 34 (97%) were positive with anti-S-100 protein, 33 (94%) with T311, 30 (85%) with A103, 26 (74%) with D5, and 25 (71%) with HMB-45. All five desmoplastic melanomas of the oral mucosa were positive for S-100 protein, four for tyrosinase, and one each for HMB-45 and A103. No desmoplastic melanoma was positive with D5. All 44 sinonasal melanomas were positive for tyrosinase and Mart-1/Melan-A (100%). Forty-three (98%) were positive with HMB-45, 42 (95%) with anti-S-100 protein, and 40 (91%) with D5. These results reveal that T311 is the most sensitive marker for sinonasal melanomas and closely approaches the sensitivity of anti-S-100 protein for oral mucosal melanomas. For desmoplastic mucosal tumors, anti-S-100 protein remains the most sensitive marker.
Prasad
M L
ML
Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Jungbluth
A A
AA
Iversen
K
K
Huvos
A G
AG
Busam
K J
KJ
D000951:Antigens, Neoplasm; D004268:DNA-Binding Proteins / Q000032:analysis / Q000096:biosynthesis; D006801:Humans; D058965:MART-1 Antigen; D008544:Melanocytes / Q000378:metabolism; D008545:Melanoma / Q000737:chemistry / Q000378:metabolism*; D008562:Membrane Glycoproteins / Q000032:analysis / Q000096:biosynthesis; D051739:Microphthalmia-Associated Transcription Factor; D014442:Monophenol Monooxygenase / Q000032:analysis / Q000096:biosynthesis; D009061:Mouth Mucosa / Q000737:chemistry / Q000378:metabolism*; D009062:Mouth Neoplasms / Q000737:chemistry / Q000378:metabolism*; D009297:Nasal Mucosa / Q000737:chemistry / Q000378:metabolism*; D009363:Neoplasm Proteins / Q000032:analysis / Q000096:biosynthesis; D009669:Nose Neoplasms / Q000737:chemistry / Q000378:metabolism*; D009418:S100 Proteins / Q000032:analysis / Q000096:biosynthesis; D014157:Transcription Factors / Q000032:analysis / Q000378:metabolism; D058951:gp100 Melanoma Antigen
D000951:Antigens, Neoplasm; D004268:DNA-Binding Proteins; D058965:MART-1 Antigen; C497234:MITF protein, human; C548667:MLANA protein, human; D008562:Membrane Glycoproteins; D051739:Microphthalmia-Associated Transcription Factor; D009363:Neoplasm Proteins; C548637:PMEL protein, human; D009418:S100 Proteins; D014157:Transcription Factors; D058951:gp100 Melanoma Antigen; D014442:Monophenol Monooxygenase